Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications.

Carlino, Francesca; Solinas, Cinzia; Orditura, Michele; Bisceglia, Maria Dezia; Pellegrino, Benedetta; Diana, Anna

Carlino, Francesca; Solinas, Cinzia; Orditura, Michele; Bisceglia, Maria Dezia; Pellegrino, Benedetta; Diana, Anna.

Afiliación

Carlino F; Medical Oncology Unit, Ospedale Ave Gratia Plena, San Felice a Cancello, Caserta, Italy.
Solinas C; Medical Oncology, Azienda Ospedaliera Universitaria (A. O. U.) Cagliari Policlinico Duilio Casula di Monserrato, Cagliari, Italy.
Orditura M; Medical Oncology Unit, Azienda Ospedaliera di Rilievo Nazionale (A.O. R. N.) Sant'Anna e San Sebastiano, Caserta, Italy.
Bisceglia MD; Department of Pharmacy, Azienda Ospedaliera di Rilievo Nazionale (A.O. R. N.) Sant'Anna e San Sebastiano, Caserta, Italy.
Pellegrino B; Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.
Diana A; Medical Oncology Unit, Ospedale del Mare, Naples, Italy.

Front Oncol ; 14: 1321654, 2024.

Article en En | MEDLINE | ID: mdl-38469228

Palabras clave

breast cancer; drug resistance; emerging technologies; heterogeneity; molecular mechanisms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google